The Resource Immunobiology of asthma and rhinitis : pathogenic factors and therapeutic options : Montreal, Canada, June, 1997 : American Thoracic Society Workshop summary, prepared by Thomas B. Casale

Immunobiology of asthma and rhinitis : pathogenic factors and therapeutic options : Montreal, Canada, June, 1997 : American Thoracic Society Workshop summary, prepared by Thomas B. Casale

Label
Immunobiology of asthma and rhinitis : pathogenic factors and therapeutic options : Montreal, Canada, June, 1997 : American Thoracic Society Workshop summary
Title
Immunobiology of asthma and rhinitis
Title remainder
pathogenic factors and therapeutic options : Montreal, Canada, June, 1997 : American Thoracic Society Workshop summary
Statement of responsibility
prepared by Thomas B. Casale
Title variation
  • American Thoracic Society Workshop summary
  • ATS workshop summary
Creator
Contributor
Subject
Genre
Language
eng
Cataloging source
NLM
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
bibliography
NLM call number
WF 553
NLM item number
A5125i 1999
http://bibfra.me/vocab/lite/organizationDate
(1997 :
http://bibfra.me/vocab/lite/organizationName
American Thoracic Society
http://library.link/vocab/relatedWorkOrContributorName
  • Casale, Thomas B
  • American Thoracic Society
http://library.link/vocab/subjectName
  • Asthma
  • Rhinitis
  • Rhinitis
  • Rhinitis
  • Asthma
  • Asthma
  • Rhinitis
  • Rhinitis
Label
Immunobiology of asthma and rhinitis : pathogenic factors and therapeutic options : Montreal, Canada, June, 1997 : American Thoracic Society Workshop summary, prepared by Thomas B. Casale
Instantiates
Publication
Bibliography note
Includes bibliographical references (pages 42-49)
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Pathogenesis -- Immune effector cells and mediators in the pathogenesis of asthma and rhinitis -- Comparison of asthma and rhinitis with respect to cells and mediators -- Effector cells and mediators -- Factors contributing to differences in pulmonary versus nasal responses -- Immune effector cells and their mediators in the pathogenesis of rhinitis -- Mechanisms of CD4+ T cell accumulation in the submucosa of the upper and lower respiratory tract in atopic rhinitis and asthma -- Leukotrienes as mediators of upper and lower airway obstruction -- Immune effector cells in asthma and rhinitis: eosinophils -- Workshop consensus -- Neurogenic pathways and the immunobiology of asthma and rhinitis -- Relationship of neurogenic pathways to immunobiology of asthma -- Immune regulation of airway neuronal activity -- Neuronal regulation of inflammation -- Relationship of neurogenic pathways to immunobiology of rhinitis -- Neurogenic inflammation of the airways -- Regulation of the parasympathetic nerves in asthma -- Workshop consensus -- Epidemiology and therapy -- Incidence, prevalence, and co-morbidity of asthma and rhinitis -- Incidence, prevalence, and morbidity of asthma -- Scope of the problem -- Definition: measurement -- Trends in hospitalization -- Trends in asthma mortality -- Access to health care -- Changes in risk factors -- Summary -- Incidence, prevalence, and morbidity of chronic rhinitis -- Early allergic rhinitis as a risk factor for childhood asthma -- Workshop consensus -- Current therapies and future prospects for the concomitant treatment of asthma and rhinitis -- Current and future therapies for asthma -- Current therapies -- Nonspecific approaches -- Theophylline -- Corticosteroids -- Specific targeted therapy: leukotriene (LT) modifiers -- Future therapies -- Nonspecific therapy -- Phosphodiesterase IV inhibitors -- Anti-T-Cell antibodies -- Specific therapy: anti-interleukin-5 -- Mechanisms of current therapy and future prospects for the therapy of rhinitis -- Pharmacokinetics: topical vs systemic drug administration -- Nasal drug distribution -- Drug groups -- Intranasal corticosteroids -- Systemic corticosteroids -- H1-antihistamines -- Ü-adrenoceptor agonists -- Cholinoreceptor antagonists -- Other drugs -- Effect of antihistamines on asthma -- Chlorpheniramine -- Azelastine -- Ketotifen -- Terfenadine -- Cetirizine -- Loratadine -- Summary -- Allergy immunotherapy for rhinitis and asthma: similarities and differences -- Effect of leukotriene modifiers -- Workshop consensus -- Conclusion -- Dr. Lazarus' perspective -- Dr. Casale's perspective -- Workshop participants
Control code
41279846
Dimensions
28 cm
Extent
iv, 49 pages
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
Label
Immunobiology of asthma and rhinitis : pathogenic factors and therapeutic options : Montreal, Canada, June, 1997 : American Thoracic Society Workshop summary, prepared by Thomas B. Casale
Publication
Bibliography note
Includes bibliographical references (pages 42-49)
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Pathogenesis -- Immune effector cells and mediators in the pathogenesis of asthma and rhinitis -- Comparison of asthma and rhinitis with respect to cells and mediators -- Effector cells and mediators -- Factors contributing to differences in pulmonary versus nasal responses -- Immune effector cells and their mediators in the pathogenesis of rhinitis -- Mechanisms of CD4+ T cell accumulation in the submucosa of the upper and lower respiratory tract in atopic rhinitis and asthma -- Leukotrienes as mediators of upper and lower airway obstruction -- Immune effector cells in asthma and rhinitis: eosinophils -- Workshop consensus -- Neurogenic pathways and the immunobiology of asthma and rhinitis -- Relationship of neurogenic pathways to immunobiology of asthma -- Immune regulation of airway neuronal activity -- Neuronal regulation of inflammation -- Relationship of neurogenic pathways to immunobiology of rhinitis -- Neurogenic inflammation of the airways -- Regulation of the parasympathetic nerves in asthma -- Workshop consensus -- Epidemiology and therapy -- Incidence, prevalence, and co-morbidity of asthma and rhinitis -- Incidence, prevalence, and morbidity of asthma -- Scope of the problem -- Definition: measurement -- Trends in hospitalization -- Trends in asthma mortality -- Access to health care -- Changes in risk factors -- Summary -- Incidence, prevalence, and morbidity of chronic rhinitis -- Early allergic rhinitis as a risk factor for childhood asthma -- Workshop consensus -- Current therapies and future prospects for the concomitant treatment of asthma and rhinitis -- Current and future therapies for asthma -- Current therapies -- Nonspecific approaches -- Theophylline -- Corticosteroids -- Specific targeted therapy: leukotriene (LT) modifiers -- Future therapies -- Nonspecific therapy -- Phosphodiesterase IV inhibitors -- Anti-T-Cell antibodies -- Specific therapy: anti-interleukin-5 -- Mechanisms of current therapy and future prospects for the therapy of rhinitis -- Pharmacokinetics: topical vs systemic drug administration -- Nasal drug distribution -- Drug groups -- Intranasal corticosteroids -- Systemic corticosteroids -- H1-antihistamines -- Ü-adrenoceptor agonists -- Cholinoreceptor antagonists -- Other drugs -- Effect of antihistamines on asthma -- Chlorpheniramine -- Azelastine -- Ketotifen -- Terfenadine -- Cetirizine -- Loratadine -- Summary -- Allergy immunotherapy for rhinitis and asthma: similarities and differences -- Effect of leukotriene modifiers -- Workshop consensus -- Conclusion -- Dr. Lazarus' perspective -- Dr. Casale's perspective -- Workshop participants
Control code
41279846
Dimensions
28 cm
Extent
iv, 49 pages
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations

Library Locations

    • University of Missouri Libraries DepositoryBorrow it
      2908 Lemone Blvd, Columbia, MO, 65211, US
      38.919360 -92.291620
Processing Feedback ...